Berndt, Ernst and Pierre Dubois (2012), Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010, IDEI Working Paper 702.
Berry, Steven T. (1994), Estimating Discrete–Choice Models of Product Differentiation, The RAND Journal of Economics, 25 (2), 242–262.
Branstetter, Lee G. , Chirantan Chatterjee, and Matthew Higgins (2011), Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry, NBER Working Paper 17188.
Brekke, Kurt R., Grasdal, Astrid L., and Tor H. Holmås (2009), Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation, European Economic Review, 53 (2), 170-185.
Cardell, N. Scott (1997), Variance Components Structures for the Extreme–Value and Logistic Distributions with Applications to Models of Heterogeneity, Econometric Theory, 13 (2), 185–213.
- Ching, Andrew (2010a), A Dynamic Oligopoly Structural Model for the Prescription Drug Market after Patent Expiration, International Economic Review, 51 (4), 11751207.
Paper not yet in RePEc: Add citation now
- Ching, Andrew (2010b), Consumer Learning and Heterogeneity: Dynamics of Demand for Prescription Drugs After Patent Expiration,International Journal of Industrial Organization, 28 (6), 619-638.
Paper not yet in RePEc: Add citation now
- Ching, Andrew, Robert Clark, Ignatius Horstmann, and Hyunwoo Lim (2012), The Effects of Publicity on Demand: The Case of Anti-cholesterol Drugs, working paper.
Paper not yet in RePEc: Add citation now
Danzon, Patricia M. and Li-Wei Chao (2000), Cross-National Price Differences for Pharmaceuticals: How Large and Why?, Journal of Health Economics, 19 (2), 159–195.
Dubois, Pierre and Laura Lasio (2014), Identifying Industry Margins with Unobserved Price Constraints: Structural Estimation on Pharmaceuticals, IDEI Working Paper No. 823.
Dunn, Abe (2012), Drug Innovations and Welfare Measures Computed from Market Demand: The Case of Anti-Cholesterol Drugs, American Economic Journal: Applied Economics, 4 (3), 167–189.
Duso, Tomaso, Annika Herr, and Moritz Suppliet (2014), The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral AntiDiabetics, , Health Economics, 23, 1036–1057.
Dutta, Antara (2011), From Free Entry to Patent Protection: Welfare Implications for the Indian Pharmaceutical Industry, The Review of Economics and Statistics, 93 (1), 160–178.
- Enemark, Ulrika, Møller, Kjeld, and Jan Sørensen (2006), The Economic Impact of Parallel Import of Pharmaceuticals, CAST - Centre for Applied Health Services Research and Technology Assessment, University of Southern Denmark.
Paper not yet in RePEc: Add citation now
EspÃn, Jaime, Rovira, Joan, and Antonio Olry de Labry (2011), WHO/HAI Project on Medicine Prices and Availability, Review Series on Pharmaceutical Pricing Policies and Interventions, Working Paper 1: External Reference Pricing; URL: http://www.haiweb.org/medicineprices/24072012/ERPfinalMay2011.pdf Ganslandt, Mattias and Keith E. Maskus (2004), Parallel Imports and the Pricing of Pharmaceutical Products: Evidence from the European Union, Journal of Health Economics, 23 (5), 1035–1057.
- Ganslandt, Mattias and Keith E. Maskus (2008), Intellectual Property Rights, Parallel Imports and Strategic Behavior, in Frontiers of Economic and Globalization.
Paper not yet in RePEc: Add citation now
Grabowski, Henry G. and John M. Vernon (1992), Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act, Journal of Law and Economics, 35, 331-350.
Grossman, Gene M. and Edwin L.-C. Lai (2008), Parallel Imports and Price Controls, the RAND Journal of Economics, 2008, 39 (2), 378–402.
Kaiser, Ulrich, Susan J. Mendez, Rønde, Thomas, and Hannes Ullrich (2014), Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark, Journal of Health Economics, 36, 174–187.
Kanavos, Panos and Joan Costa-Font (2005), Pharmaceutical Parallel Trade in Europe: Stakeholder and Competition Effects, Economic Policy, 20 (44), 751–798.
- Kyle, Margaret (2009), Parallel Trade in Pharmaceuticals: Firm Responses and Competition Policy, in B. Hawk (Ed.), International Antitrust Law & Policy: Fordham Competition Law, Juris Publishing, New York.
Paper not yet in RePEc: Add citation now
Kyle, Margaret (2011), Strategic Responses to Parallel Trade, The B.E. Journal of Economic Analysis & Policy, 11 (2).
López-Casasnovas, Guillem and Jaume Puig-Junoy (2000), Review of the Literature on Reference Pricing, Universitat Pompeu Fabra, mimeo.
Li, Changying and Keith E. Maskus (2006), The Impact of Parallel Imports on Investments in Cost–Reducing Research and Development, Journal of International Economics, 68 (2), 443–455.
- Madsen, Mette and Jørgen Videbæk (2004), Hjertestatistik - Heart Statistics 2004, Hjerteforeningen og Institut for Folkesundhed. http://www.hjerteforeningen.dk McFadden, Daniel (1978), Modelling the Choice of Residential Location, in A. Karlqvist, L. Lundqvist, F. Snickars, and J. Weibull (eds.), Spatial Interaction Theory and Planning Models, Amsterdam: North-Holland.
Paper not yet in RePEc: Add citation now
Pavcnik, Nina (2002), Do Pharmaceutical Prices Respond to Potential Patient Out-ofpocket Expenses?, The RAND Journal of Economics, 33 (3), 469–487.
- Petrucci, Carlo (2010), Parallel Trade of Pharmaceutical Products: The ECJ Finally Speaks – Comment on GlaxoSmithKline, European Law Review, 35 (2), 275–286.
Paper not yet in RePEc: Add citation now
- Roth, Gregory A., Stephan D. Fihn, Ali H. Mokdad, Wichai Aekplakorn, Toshihiko Hasegawa, and Stephen S. Lim (2011) High total serum cholesterol, medication cov25 erage and therapeutic control: an analysis of national health examination survey data from eight countries, Bulletin of the World Health Organization, 89 (2), 92-101.
Paper not yet in RePEc: Add citation now
Scott Morton, Fiona M. (2000), Barriers to Entry, Brand Advertising, and Generic Entry in the US Pharmaceutical Industry, International Journal of Industrial Organization, 18 (7), 1085-1104.
- Stern, Scott (1996), Market Definition and the Returns to Innovation: Substitution Patterns in Pharmaceutical Markets, MIT Sloan School & NBER working paper.
Paper not yet in RePEc: Add citation now
Szymanski, Stefan and Tommaso M. Valletti (2006), Parallel Trade, International Exhaustion and Intellectual Property Rights: A Welfare Analysis, the Journal of Industrial Economics, 54 (4), 499–526.
- Tsouloufas, Georgios (2011), Limiting Pharmaceutical Parallel Trade in the European Union: Regulatory and Economic Justifications, European Law Review, 36 (3), 385– 404.
Paper not yet in RePEc: Add citation now
Valletti, Tommaso M. (2006), Differential Pricing, Parallel Trade, and the Incentive to Invest, Journal of International Economics, 70 (1), 314–324.
Verboven, Frank (1996), International Price Discrimination in the European Car Market, the RAND Journal of Economics, 27 (2), 240–268.